Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.42 | -1.41 | -0.83 | 0.26 |
| FCF Yield | 0.18% | 0.70% | 3.04% | 4.43% |
| EV / EBITDA | 40.08 | 12.35 | 9.85 | 7.21 |
| Quality | ||||
| ROIC | 10.29% | 4.28% | 5.24% | 6.94% |
| Gross Margin | 44.11% | 43.52% | 45.22% | 47.42% |
| Cash Conversion Ratio | 3.59 | 0.89 | 0.71 | 0.62 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.13% | 5.01% | 2.53% | -0.04% |
| Free Cash Flow Growth | -84.93% | -70.50% | -12.63% | -21.13% |
| Safety | ||||
| Net Debt / EBITDA | 13.75 | 2.43 | 1.90 | 1.51 |
| Interest Coverage | 0.87 | 3.14 | 5.91 | 11.33 |
| Efficiency | ||||
| Inventory Turnover | 1.35 | 1.40 | 1.14 | 1.29 |
| Cash Conversion Cycle | 222.74 | 290.62 | 346.37 | 308.83 |